DTxL

DTxL is a private U.S.-based digital therapeutics and digital medicine company focused on building, validating, operating, and commercializing solutions for pharmaceutical and medtech clients. Rather than a traditional drug-development biotech, the company appears to function as a commercialization and services platform helping partners bring digital health interventions into care delivery. Publicly available profiles describe DTxL as active, for-profit, and headquartered in Chicago, Illinois. Available sources also indicate it has operated as a joint venture involving Boston Consulting Group Digital Ventures and Abundant Venture Partners. The company appears to be healthcare-focused, but there is no clear evidence from public sources of an internal therapeutic drug pipeline or named molecular assets.